Great news but I would have liked more precise data. No numbers of patients trialled and did anyone see any ann re trials for Covid at all ?
Ann have been made re trials via a WA firm this qtr for Glaucoma etc, but this is out of left field.
Big Pharma always welcome, to help fund research and to bring to market, but not at the expense of buying us out too cheaply compared to end value of company. A JV would be better for us, but not if company register moved off-shore. Keep it in Australia please.
Ann: Results from Pulmonary Studies, page-58
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.639M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 52000 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 27000 | 1 |
View Market Depth
| Last trade - 08.35am 01/08/2024 (20 minute delay) ? |
| NSB (ASX) Chart |
Day chart unavailable